LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis

BACKGROUND: Cisplatin (DDP) is a major chemotherapeutic drug which was widely used for cervical cancer (CC) patients with advanced or recurrent although its limitation in the development of resistance. LncRNA nicotinamide nucleotide transhydrogenase-antisense RNA1 (NNT-AS1) has been reported to be i...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Cell Int
Main Authors: Liu, Yanjie, Guo, Ruixia, Qiao, Yuhuan, Han, Liping, Liu, Mingzhu
Format: Artigo
Language:Inglês
Published: BioMed Central 2020
Subjects:
Primary Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7247171/
https://ncbi.nlm.nih.gov/pubmed/32489326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01278-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items